Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RYZB | AXSM | RNA | ||
Company | Rayzebio Inc | Axsome Thera | Avidity Biosciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 62.49 | 79.12 | 38.56 | ||
High | 62.50 | 80.25 | 38.94 | ||
Low | 62.48 | 78.64 | 36.77 | ||
Last | 62.49 | 80.21 | 37.21 | ||
Change | +0.01 | +1.28 | -1.59 | ||
% Change | +0.02% | +1.62% | -4.10% | ||
Volume | 282,700 | 252,344 | 951,103 | ||
20-Day Average Volume | 318,060 | 873,247 | 2,475,312 | ||
Previous Close | 62.48 | 78.93 | 38.80 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 62.28 | 76.09 | 36.29 | ||
20-Day Raw Stochastic | 95.83% | 88.86% | 68.80% | ||
20-Day Relative Strength | 86.10% | 57.19% | 58.32% | ||
Weighted Alpha | N/A | +11.29 | +157.61 | ||
Today's Opinion | N/A | 56% Buy | 100% Buy | ||
Previous Opinion | N/A | 56% Buy | 100% Buy | ||
Last Month's Opinion | N/A | 24% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.13% since 02/15/24 | +3.49% since 06/26/24 | -7.82% since 06/26/24 | ||
Low | 62.42 on 02/16/24 | 76.00 on 06/27/24 | 36.77 on 07/03/24 | ||
High | 62.51 on 02/22/24 | 81.78 on 07/01/24 | 41.87 on 07/02/24 | ||
1-Month | |||||
%Chg | +0.87% since 01/23/24 | +6.78% since 06/03/24 | +36.71% since 06/03/24 | ||
Low | 61.86 on 01/24/24 | 64.11 on 06/11/24 | 25.30 on 06/07/24 | ||
High | 62.51 on 02/22/24 | 81.78 on 07/01/24 | 42.00 on 06/14/24 | ||
3-Month | |||||
%Chg | +167.05% since 11/22/23 | +8.59% since 04/03/24 | +38.10% since 04/03/24 | ||
Low | 22.14 on 11/27/23 | 64.11 on 06/11/24 | 21.56 on 04/04/24 | ||
High | 62.51 on 02/22/24 | 81.78 on 07/01/24 | 42.00 on 06/14/24 | ||
6-Month | |||||
%Chg | N/A since 09/15/23 | +4.89% since 01/03/24 | +284.83% since 01/03/24 | ||
Low | 17.95 on 09/26/23 | 64.11 on 06/11/24 | 8.95 on 01/05/24 | ||
High | 62.51 on 02/22/24 | 98.40 on 02/12/24 | 42.00 on 06/14/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 3,744,400 | 3,748,859 | 3,710,716 | ||
Shares Outstanding, K | 59,920 | 47,496 | 95,637 | ||
Annual Sales | 0 | 270,600,000 | 9,560,000 | ||
Annual Net Income | -68,600,000 | -239,240,000 | -212,220,000 | ||
Last Quarter Sales | 0 | 75,000,000 | 3,540,000 | ||
Last Quarter Net Income | -18,190,000 | -68,360,000 | -68,860,000 | ||
60-Month Beta | N/A | 1.26 | 0.90 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.26 on 11/13/23 | -1.09 on 05/06/24 | -0.79 on 05/09/24 | ||
Latest Earnings Date | 03/04/24 | 08/05/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |